Covaxin "Effectively Neutralises" Delta Variant: Top US Health Institute | Read

PUBLISHED ON: June 30, 2021 | Duration: 0 min, 33 sec

facebooktwitteremailkoo
loading..
India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US' National Institute of Health has said. The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the UK and India, respectively.
ALSO WATCH
चीन में कोविड नीति के विरोध में प्रदर्शन जारी, "शी जिनपिंग गद्दी छोड़ो" के लगे नारे

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com